Cytochrome P450 3A4 (CYP3A4) Inhibitor Screening Kit (Fluorometric)
货号：
K702-200 基本售价：
6915.5 元 规格：
200assays
产品信息
概述| 货号 | K702-200 |
| 描述 | Cytochrome P450 3A4 (CYP3A4, EC 1.14.13.157) is a member of the cytochrome P450 monooxidase (CYP) family of microsomal xenobiotic metabolism enzymes. CYPs are membrane-bound hemeproteins responsible for Phase I biotransformation reactions, in which lipophilic drugs and other xenobiotic compounds are transformed to more hydrophilic products to facilitate excretion from the body. CYP3A4 is expressed in high levels in the liver and intestines, where it catalyzes oxidation of an extraordinarily wide variety of structurally distinct ligands. More than half of all small molecule drugs commonly used by humans are metabolized by CYP3A4 and inhibition of CYP3A4-mediated metabolism is a common cause of adverse drug/drug and drug/food interactions and toxicity. In addition, for drugs whose pharmacological activity requires metabolism from a pro-drug form, CYP3A4 inhibition can lead to decreased drug efficacy. BioVision’s CYP3A4 Inhibitor Screening Kit enables rapid screening of drugs and other new chemical entities (NCEs) for compound-CYP3A4 interaction in a reliable, high-throughput fluorescence-based assay. The kit provides a yeast microsomal preparation of human CYP3A4 and cytochrome P450 reductase (CPR) enzymes. The assay utilizes a non-fluorescent CYP3A4 substrate that is converted into a highly fluorescent metabolite detected in the visible range (Ex/Em = 535/587 nm), ensuring a high signal-to-background ratio with little interference by autofluorescence. The concentration of fluorogenic substrate used for screening is roughly equivalent to its Km for CYP3A4, facilitating detection of weak competitive inhibitors. The kit contains a complete set of reagents sufficient for performing 200 reactions in a 96-well plate format. |
| 同种亚型 | Rabbit IgG |
| 来源宿主 | Rabbit |
性能| 供应商 | Biovision |
| 检测类型 | Fluorescence (Ex/Em 535/587 nm) • Species reactivity - Eukaryotes• Applications - Rapid, high-throughput screening of drugs and novel ligands. - Development of structure-activity relationship (SAR) models to predict CYP3A4 inhibition lia |
| 样本类型以及上样量 | • Samples containing drugs, inhibitors or ligands (compounds that can interact and affect CYP3A activity) |
| 产品特色 | • Simple, highly sensitive, high-throughput compatible • Rapid screening of CYP3A4 inhibitors or ligands • Kit includes the canonical CYP3A inhibitor ketoconazole and a stable, recombinant human CYP3A4 co-expressed with NADPH Reductase |
| 试剂盒组分 | • CYP3A4 Assay Buffer• Resorufin Standard (5 mM in DMSO)• CYP3A4 Inhibitor (Ketoconazole)• NADPH Generating System (100X)• β-NADP+ Stock (100X)• CYP3A4 Substrate• Recombinant Human CYP3A4 |
| 运输条件 | Blue Ice |
| 存放说明 | -20℃ |
